Your browser doesn't support javascript.
loading
Tannic acid coated nanosuspension for oral delivery of chrysin intended for anti-schizophrenic effect in mice.
Salama, Abeer; Hamed Salama, Alaa; Hasanein Asfour, Marwa.
Afiliación
  • Salama A; Pharmacology Department, National Research Centre, El- Buhouth St., Dokki, Cairo 12622, Egypt.
  • Hamed Salama A; Pharmaceutical Technology Department, National Research Centre, El-Buhouth St., Dokki, Cairo 12622, Egypt; Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Ahram Canadian University, 6(th) of October City, Cairo, Egypt.
  • Hasanein Asfour M; Pharmaceutical Technology Department, National Research Centre, El-Buhouth St., Dokki, Cairo 12622, Egypt. Electronic address: marwaasfour@hotmail.com.
Int J Pharm ; 656: 124085, 2024 May 10.
Article en En | MEDLINE | ID: mdl-38580073
ABSTRACT
Chrysin is a flavonoid drug with numerous therapeutic activities. It suffers from low intestinal absorption owing to its hydrophobicity. Therefore, the aim of this study is to exploit the efficient technique of nanosuspension (NSP) to formulate chrysin-NSP coated with tannic acid (TA) to improve the solubility and anti-schizophrenic activity of chrysin. A 23 full factorial design was constructed where the independent factors were type of polymer, surfactant concentration (0.5 or 1 %) and the aqueous phase volume (5 or 15 mL), while the dependent responses were the particle size (PS) of the obtained formulation as well as the % chrysin dissolved after 2 h (Q2h). The optimum formulation (NSP-4) composed of 1 % PEG 400 and 1 % Cremophor RH40 in 15 mL aqueous phase. It achieved a PS and Q2h values of 108.00 nm and 38.77 %, respectively. NSP-4 was then coated with TA (TA-coated NSP-4) for further enhancement of chrysin solubility. TA-coated NSP-4 revealed PS and zeta potential values of 150 ± 14 nm and -32.54 ± 2.45 mV, respectively. After 6 h, chrysin dissolved % were 53.97 and 80.22 for uncoated NSP-4 and TA-coated NSP-4, respectively, compared with only 9.47 for free chrysin. The developed formulations and free chrysin were assessed regarding their effect on schizophrenia induced in mice by cuprizone (CPZ). Treatment with the developed formulations and free chrysin ameliorated demyelination and behavioral deficit induced by CPZ via elevating MBP and PI3K/PKC activities as well as reducing GFAP expression levels. The developed formulations and free chrysin inhibited Galactin-3 and TGF-ß expressions and stimulated GST antioxidant enzyme. Furthermore, they maintained the balances in glutamatergic and dopaminergic neurotransmission via modulation on neuregulin-1 and alleviated nuclear pyknosis and degeneration in the neurons. The order of activity was TA-coated NSP-4 > NSP-4 > free chrysin.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Esquizofrenia / Solubilidad / Taninos / Flavonoides / Nanopartículas / Polifenoles Límite: Animals Idioma: En Revista: Int J Pharm Año: 2024 Tipo del documento: Article País de afiliación: Egipto Pais de publicación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Esquizofrenia / Solubilidad / Taninos / Flavonoides / Nanopartículas / Polifenoles Límite: Animals Idioma: En Revista: Int J Pharm Año: 2024 Tipo del documento: Article País de afiliación: Egipto Pais de publicación: Países Bajos